{"id":5573,"date":"2013-07-01T08:39:00","date_gmt":"2013-07-01T08:39:00","guid":{"rendered":"https:\/\/www.adacyte.com\/?post_type=scientific-corner&p=5573"},"modified":"2021-07-12T07:46:38","modified_gmt":"2021-07-12T07:46:38","slug":"questionnaire-based-assessment-of-patients-acceptability-of-leukocytapheresis-for-the-treatment-of-inflammatory-bowel-disease","status":"publish","type":"scientific-corner","link":"https:\/\/www.adacyte.com\/es\/professional\/scientific-corner\/questionnaire-based-assessment-of-patients-acceptability-of-leukocytapheresis-for-the-treatment-of-inflammatory-bowel-disease\/","title":{"rendered":"Questionnaire Based Assessment of Patients’ Acceptability of Leukocytapheresis for the Treatment of Inflammatory Bowel Disease."},"content":{"rendered":"
\n

Kazuko Nagase<\/a> 1<\/a><\/sup>, Ken Fukuanga<\/a>, Yoko Yokoyama<\/a>, Koji Kamikozuru<\/a>, Hiroto Miwa<\/a>, Shiro Nakamura<\/a>, Ther Apher Dial. 2013 Oct;17(5):490-7.<\/p>\n<\/div>\n\n

\n

The aim of the present study was to assess patients’ acceptance of therapeutic leukocytapheresis known as cytapheresis (CAP) for the treatment of an active flare of inflammatory bowel disease (IBD).<\/p>\n<\/div>\n\n

\n

https:\/\/pubmed.ncbi.nlm.nih.gov\/24107277\/<\/a><\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"

Kazuko Nagase 1, Ken Fukuanga, Yoko Yokoyama, Koji Kamikozuru, Hiroto Miwa, Shiro Nakamura, Ther Apher Dial. 2013 Oct;17(5):490-7. The aim of the present study was to assess patients’ acceptance of therapeutic leukocytapheresis known as cytapheresis (CAP) for the treatment of an active flare of inflammatory bowel disease (IBD). https:\/\/pubmed.ncbi.nlm.nih.gov\/24107277\/<\/p>\n","protected":false},"template":"","scientific_tags":[159,380,374,381,382,383,306],"class_list":["post-5573","scientific-corner","type-scientific-corner","status-publish","hentry","scientific_tags-crohns-disease","scientific_tags-cytapheresis","scientific_tags-inflammatory-bowel-disease","scientific_tags-logistic-regression-analysis","scientific_tags-patients-acceptability","scientific_tags-questionnaire","scientific_tags-ulcerative-colitis"],"acf":{"sc_authors":""},"yoast_head":"\nQuestionnaire Based Assessment of Patients' Acceptability of Leukocytapheresis for the Treatment of Inflammatory Bowel Disease. - Adacyte<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/questionnaire-based-assessment-of-patients-acceptability-of-leukocytapheresis-for-the-treatment-of-inflammatory-bowel-disease\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Questionnaire Based Assessment of Patients' Acceptability of Leukocytapheresis for the Treatment of Inflammatory Bowel Disease. - Adacyte\" \/>\n<meta property=\"og:description\" content=\"Kazuko Nagase 1, Ken Fukuanga, Yoko Yokoyama, Koji Kamikozuru, Hiroto Miwa, Shiro Nakamura, Ther Apher Dial. 2013 Oct;17(5):490-7. The aim of the present study was to assess patients’ acceptance of therapeutic leukocytapheresis known as cytapheresis (CAP) for the treatment of an active flare of inflammatory bowel disease (IBD). https:\/\/pubmed.ncbi.nlm.nih.gov\/24107277\/\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/questionnaire-based-assessment-of-patients-acceptability-of-leukocytapheresis-for-the-treatment-of-inflammatory-bowel-disease\/\" \/>\n<meta property=\"og:site_name\" content=\"Adacyte\" \/>\n<meta property=\"article:modified_time\" content=\"2021-07-12T07:46:38+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minuto\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/questionnaire-based-assessment-of-patients-acceptability-of-leukocytapheresis-for-the-treatment-of-inflammatory-bowel-disease\/\",\"url\":\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/questionnaire-based-assessment-of-patients-acceptability-of-leukocytapheresis-for-the-treatment-of-inflammatory-bowel-disease\/\",\"name\":\"Questionnaire Based Assessment of Patients' Acceptability of Leukocytapheresis for the Treatment of Inflammatory Bowel Disease. - Adacyte\",\"isPartOf\":{\"@id\":\"https:\/\/www.adacyte.com\/#website\"},\"datePublished\":\"2013-07-01T08:39:00+00:00\",\"dateModified\":\"2021-07-12T07:46:38+00:00\",\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/questionnaire-based-assessment-of-patients-acceptability-of-leukocytapheresis-for-the-treatment-of-inflammatory-bowel-disease\/\"]}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.adacyte.com\/#website\",\"url\":\"https:\/\/www.adacyte.com\/\",\"name\":\"Adacyte\",\"description\":\"Adacyte Therapeutics\",\"publisher\":{\"@id\":\"https:\/\/www.adacyte.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.adacyte.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.adacyte.com\/#organization\",\"name\":\"Adacyte\",\"url\":\"https:\/\/www.adacyte.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.adacyte.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.adacyte.com\/wp-content\/uploads\/2021\/01\/logo-adacyte.svg\",\"contentUrl\":\"https:\/\/www.adacyte.com\/wp-content\/uploads\/2021\/01\/logo-adacyte.svg\",\"width\":165,\"height\":46,\"caption\":\"Adacyte\"},\"image\":{\"@id\":\"https:\/\/www.adacyte.com\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Questionnaire Based Assessment of Patients' Acceptability of Leukocytapheresis for the Treatment of Inflammatory Bowel Disease. - Adacyte","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.adacyte.com\/professional\/scientific-corner\/questionnaire-based-assessment-of-patients-acceptability-of-leukocytapheresis-for-the-treatment-of-inflammatory-bowel-disease\/","og_locale":"es_ES","og_type":"article","og_title":"Questionnaire Based Assessment of Patients' Acceptability of Leukocytapheresis for the Treatment of Inflammatory Bowel Disease. - Adacyte","og_description":"Kazuko Nagase 1, Ken Fukuanga, Yoko Yokoyama, Koji Kamikozuru, Hiroto Miwa, Shiro Nakamura, Ther Apher Dial. 2013 Oct;17(5):490-7. The aim of the present study was to assess patients’ acceptance of therapeutic leukocytapheresis known as cytapheresis (CAP) for the treatment of an active flare of inflammatory bowel disease (IBD). https:\/\/pubmed.ncbi.nlm.nih.gov\/24107277\/","og_url":"https:\/\/www.adacyte.com\/professional\/scientific-corner\/questionnaire-based-assessment-of-patients-acceptability-of-leukocytapheresis-for-the-treatment-of-inflammatory-bowel-disease\/","og_site_name":"Adacyte","article_modified_time":"2021-07-12T07:46:38+00:00","twitter_card":"summary_large_image","twitter_misc":{"Tiempo de lectura":"1 minuto"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.adacyte.com\/professional\/scientific-corner\/questionnaire-based-assessment-of-patients-acceptability-of-leukocytapheresis-for-the-treatment-of-inflammatory-bowel-disease\/","url":"https:\/\/www.adacyte.com\/professional\/scientific-corner\/questionnaire-based-assessment-of-patients-acceptability-of-leukocytapheresis-for-the-treatment-of-inflammatory-bowel-disease\/","name":"Questionnaire Based Assessment of Patients' Acceptability of Leukocytapheresis for the Treatment of Inflammatory Bowel Disease. - Adacyte","isPartOf":{"@id":"https:\/\/www.adacyte.com\/#website"},"datePublished":"2013-07-01T08:39:00+00:00","dateModified":"2021-07-12T07:46:38+00:00","inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.adacyte.com\/professional\/scientific-corner\/questionnaire-based-assessment-of-patients-acceptability-of-leukocytapheresis-for-the-treatment-of-inflammatory-bowel-disease\/"]}]},{"@type":"WebSite","@id":"https:\/\/www.adacyte.com\/#website","url":"https:\/\/www.adacyte.com\/","name":"Adacyte","description":"Adacyte Therapeutics","publisher":{"@id":"https:\/\/www.adacyte.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.adacyte.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/www.adacyte.com\/#organization","name":"Adacyte","url":"https:\/\/www.adacyte.com\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.adacyte.com\/#\/schema\/logo\/image\/","url":"https:\/\/www.adacyte.com\/wp-content\/uploads\/2021\/01\/logo-adacyte.svg","contentUrl":"https:\/\/www.adacyte.com\/wp-content\/uploads\/2021\/01\/logo-adacyte.svg","width":165,"height":46,"caption":"Adacyte"},"image":{"@id":"https:\/\/www.adacyte.com\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/www.adacyte.com\/es\/wp-json\/wp\/v2\/scientific-corner\/5573","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.adacyte.com\/es\/wp-json\/wp\/v2\/scientific-corner"}],"about":[{"href":"https:\/\/www.adacyte.com\/es\/wp-json\/wp\/v2\/types\/scientific-corner"}],"wp:attachment":[{"href":"https:\/\/www.adacyte.com\/es\/wp-json\/wp\/v2\/media?parent=5573"}],"wp:term":[{"taxonomy":"scientific_tags","embeddable":true,"href":"https:\/\/www.adacyte.com\/es\/wp-json\/wp\/v2\/scientific_tags?post=5573"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}